Skip to main content
Log in

Airway obstruction and the risk of myocardial infarction and death from coronary heart disease: a national health examination survey with a 33-year follow-up period

  • RESPIRATORY EPIDEMIOLOGY
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Chronic obstructive pulmonary disease (COPD) has been associated with coronary mortality. Yet, data about the association between COPD and acute myocardial infarction (MI) remain scarce. We aimed to study airway obstruction as a predictor of MI and coronary mortality among 5576 Finnish adults who participated in a national health examination survey between 1978 and 1980. Subjects underwent spirometry, had all necessary data, showed no indications of cardiovascular disease at baseline, and were followed up through record linkage with national registers through 2011. The primary outcome consisted of a major coronary event—that is, hospitalization for MI or coronary death, whichever occurred first. We specified obstruction using the lower limit of normal categorization. Through multivariate analysis adjusted for potential confounding factors for coronary heart disease, hazard ratios (HRs) (with the 95% confidence intervals in parentheses) of a major coronary event, MI, and coronary death reached 1.06 (0.79–1.42), 0.84 (0.54–1.31), and 1.40 (1.04–1.88), respectively, in those with obstruction compared to others. However, in women aged 30–49 obstruction appeared to predict a major coronary event, where the adjusted HR reached 4.21 (1.73–10.28). In conclusion, obstruction appears to predict a major coronary event in younger women only, whereas obstruction closely associates with the risk of coronary death independent of sex and age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Vogelmeier CF, Criner GJ, Martínez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J. 2017;6(49):1700214. doi: 10.1183/13993003.00214-2017. http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/. Accessed April 2017.

  2. World Health organization (WHO), Medical center, fact sheets about Cardio vascular diseases. http://www.who.int/mediacentre/factsheets/fs317/en/. Accessed April 2017.

  3. World Health organization (WHO), Medical center, fact sheets about COPD. Available from: http://www.who.int/respiratory/copd/en/. Accessed Dec 2016.

  4. Miller J, Edwards LD, Agusti A, et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013;107:1376–84. doi:10.1016/j.rmed.2013.05.001.

    Article  PubMed  Google Scholar 

  5. Ford ES, Wheaton AG, Mannino DM, Presley-Cantrell L, Li C, Croft JB. Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007–2010. Respir Res. 2012;. doi:10.1186/1465-9921-13-115.

    PubMed  PubMed Central  Google Scholar 

  6. Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulm Dis. 2009;4:337–49.

    Article  Google Scholar 

  7. Lange P, Mogelvang R, Marott JL, Vestbo J, Jensen JS. Cardiovascular morbidity in COPD: a study of the general population. COPD. 2010;7:5–10. doi:10.3109/15412550903499506.

    Article  PubMed  Google Scholar 

  8. Izquierdo JL, Martínez A, Guzmán E, de Lucas P, Rodríguez JM. Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors. Int J Chron Obstruct Pulm Dis. 2010;5:387–94.

    Article  CAS  Google Scholar 

  9. Schneider C, Bothner U, Jick SS, Meier CR. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010;25:253–60. doi:10.1007/s10654-010-9435-7.

    Article  PubMed  Google Scholar 

  10. Mullerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular comorbidity in COPD systematic literature review. Chest. 2013;144:1163–78. doi:10.1378/chest.12-2847.

    Article  PubMed  Google Scholar 

  11. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128:2068–75.

    Article  PubMed  Google Scholar 

  12. Mattila T, Vasankari T, Kanervisto M, Laitinen T, Impivaara O, Rissanen H, et al. Association between all-cause and cause-specific mortality and the GOLD stages 1–4: a 30-year follow-up among Finnish adults. Respir Med. 2015;109:1012–8. doi:10.1016/j.rmed.2015.06.002.

    Article  PubMed  Google Scholar 

  13. Baughman P, Marott JL, Lange P, et al. Combined effect of lung function level and decline increases morbidity and mortality risks. Eur J Epidemiol. 2012;27:933–43. doi:10.1007/s10654-012-9750-2.

    Article  PubMed  Google Scholar 

  14. Sode BF, Dahl M, Nordestgaard BG. Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals. Eur Heart J. 2011;32:2365–75. doi:10.1093/eurheartj/ehr338.

    Article  PubMed  Google Scholar 

  15. Eriksson B, Lindberg A, Mullerova H, Ronmark E, Lundback B. Association of heart diseases with COPD and restrictive lung function—results from a population survey. Respir Med. 2013;107:98–106. doi:10.1016/j.rmed.2012.09.011.

    Article  PubMed  Google Scholar 

  16. Rothnie KJ, Yan R, Smeeth L, Quint JK. Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMJ Open. 2015;. doi:10.1136/bmjopen-2015-007824.

    PubMed  PubMed Central  Google Scholar 

  17. Ukena C, Mahfoud F, Kindermann M, et al. The cardiopulmonary continuum systemic inflammation as ‘common soil’ of heart and lung disease. Int J Cardiol. 2010;145:172–6. doi:10.1016/j.ijcard.2010.04.082.

    Article  PubMed  Google Scholar 

  18. Aromaa A, Heliövaara M, Impivaara O, et al. Health, functional limitations and need for care in Finland. Basic results from the Mini-Finland Health Survey (in Finnish with English Summary). Helsinki and Turku, Publications of the Social Insurance Institution 1989. http://hdl.handle.net/10138/162843. Accessed Jan 2017.

  19. Aromaa A, Heliövaara M, Knekt P, Reunanen A, Impivaara O, Maatela J. Cardiovascular and respiratory survey methods. Part 2 (in Finnish with English summary). Helsinki and Turku, Publications of the Social Insurance Institution 1985.  http://hdl.handle.net/10138/162384. Accessed Jan 2017.

  20. National Institute for Health and Welfare in Finland. https://www.thl.fi/en/web/thlfi-en/research-and-expertwork/population-studies/finnish-mobile-clinic/mini-finland-health-survey. Accessed Dec 2016.

  21. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–68.

    Article  CAS  PubMed  Google Scholar 

  22. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324–43. doi:10.1183/09031936.00080312.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Carr JJ, Drekter IJ. Simplified rapid technic for the extraction and determination of serum chlesterol without saponification. Clin Chem. 1956;2:353–68.

    CAS  PubMed  Google Scholar 

  24. Statistics Finland. http://www.stat.fi/index_en.html, http://www.stat.fi/til/ksyyt/2005/ksyyt_2005_2006-10-31_luo_002.html. Accessed 2011.

  25. National Institute for Health and Welfare, Care Register for Health Care (HILMO). In English: https://www.thl.fi/en/web/thlfi-en/statistics/data-collection. In Finnish: https://www.thl.fi/fi/tilastot/tiedonkeruut/hoitoilmoitusjarjestelma-hilmo. Accessed Dec 2016.

  26. Heistaro S. Methodology Report: Heath 2000 Survey. Publications of the National Public Health Institute, Helsinki 2008. http://urn.fi/URN:NBN:fi-fe201204193320.

  27. Bursi F, Vassallo R, Weston SA, Killian JM, Roger VL. Chronic obstructive pulmonary disease after myocardial infarction in the community. Am Heart J. 2010;160:95–101. doi:10.1016/j.ahj.2010.05.004.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Rodríguez LA, Wallander MA, Martín-Merino E, Johansson S. Heart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care study. Respir Med. 2010;104:1691–9. doi:10.1016/j.rmed.2010.04.018.

    Article  PubMed  Google Scholar 

  29. Hawkins NM, Huang Z, Pieper KS, et al. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Eur J Heart Fail. 2009;11:292–8. doi:10.1093/eurjhf/hfp001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Andell P, Koul S, Martinsson A, et al. Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction. Open Heart. 2014;. doi:10.1136/openhrt-2013-000002.

    PubMed  PubMed Central  Google Scholar 

  31. Bucholz EM, Butala NM, Rathore SS, Dreyer RP, Lansky AJ, Krumholz HM. Sex differences in long-term mortality after myocardial infarction: a systematic review. Circulation. 2014;130:757–67. doi:10.1161/CIRCULATIONAHA.114.009480.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Khamis RY, Ammari T, Mikhail GW. Gender differences in coronary heart disease. Heart. 2016;102:1142–9. doi:10.1136/heartjnl-2014-306463.

    Article  CAS  PubMed  Google Scholar 

  33. Pajunen P, Koukkunen H, Ketonen M, et al. The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease. Eur J Cardiovasc Prev Rehabil. 2005;12:132–7.

    PubMed  Google Scholar 

  34. Kouzouna A, Gilchrist FJ, Ball V, et al. A systematic review of early life factors which adversely affect subsequent lung function. Paediatr Respir Rev. 2016;20:67–75. doi:10.1016/j.prrv.2016.03.003.

    CAS  PubMed  Google Scholar 

  35. Chu A, De Beritto T. The perinatal origins of cardiovascular disease. Pediatr Ann. 2015;44:e254–9. doi:10.3928/00904481-20151112-07.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

A Doctoral Candidate Position at the University of Helsinki/Hospital District of Helsinki and Uusimaa (from June 2016) awarded to the first author allowed for the write-up of our analysis. We wish to thank Vanessa Fuller for English-language revisions to this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tiina Mattila.

Ethics declarations

Conflict of interest

The corresponding author Tiina Mattila completed this study through financial support from the Hospital District of Helsinki and Uusimaa (a Doctoral Candidate Position in the Doctoral Programme of Clinical Research at the University of Helsinki/Hospital District of Helsinki and Uusimaa from June 2016). Statistical analyses in this study were completed by the corresponding author and the National Institute for Health and Welfare in Helsinki, Finland as a function of that agency’s work. All other co-authors completed the work related to this study as a function of their regular duties. The corresponding author and none of the other authors have any relevant conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mattila, T., Vasankari, T., Rissanen, H. et al. Airway obstruction and the risk of myocardial infarction and death from coronary heart disease: a national health examination survey with a 33-year follow-up period. Eur J Epidemiol 33, 89–98 (2018). https://doi.org/10.1007/s10654-017-0278-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-017-0278-3

Keywords

Navigation